Explore how compounding pharmacies can support personalized HRT treatment plans, helping providers address changing symptoms and individual needs during perimenopause.
The latest compounding news, articles and updates from our pharmacy network.
Explore how compounding pharmacies can support personalized HRT treatment plans, helping providers address changing symptoms and individual needs during perimenopause.
Explore how compounding pharmacies can support personalized HRT treatment plans, helping providers address changing symptoms and individual needs during perimenopause.
Explore how compounding pharmacies can support personalized HRT treatment plans, helping providers address changing symptoms and individual needs during perimenopause.
Each month, Industry Insights highlights a few of the stories, trends, and regulatory updates making waves across healthcare, wellness, and personalized medicine.
Peptides have received renewed attention recently, especially following the FDA’s most recent advisory committee meeting. The advisory committee evaluated seven peptides for potential inclusion on the Section 503A Bulks List and ultimately decided to recommend six of the seven for inclusion, including BPC-157, KPV, TB-500, MOTS-C, Semax, and Epitalon, but it did not recommend emideltide… Read more
